Vanilloid receptors mediate adrenergic nerve- and CGRP-containing nerve-dependent vasodilation induced by nicotine in rat mesenteric resistance arteries

被引:27
作者
Eguchi, S [1 ]
Tezuka, S [1 ]
Hobara, N [1 ]
Akiyama, S [1 ]
Kurosaki, Y [1 ]
Kawasaki, H [1 ]
机构
[1] Okayama Univ, Grad Sch Nat Sci & Technol, Dept Clin Pharmaceut Sci, Okayama 7008530, Japan
关键词
nicotine; vasodilation; calcitonin gene-related peptide-containing nerves; nicotinic receptor; vanilloid receptor-1; adrenergic nerves; rat mesenteric resistance artery;
D O I
10.1038/sj.bjp.0705773
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
1 Previous studies showed that nicotine induces adrenergic nerve-dependent vasodilation that is mediated by endogenous calcitonin gene-related peptide (CGRP) released from CGRP-containing (CGRPergic) nerves. The mechanisms underlying the nicotine-induced vasodilation were further studied. 2 Rat mesenteric vascular beds without endothelium were contracted by perfusion with Krebs solution containing methoxamine, and the perfusion pressure was measured with a pressure transducer. 3 Perfusion of nicotine (1-100 muM) for 1 min caused concentration-dependent vasodilation. Capsazepine (vanilloid receptor-1 antagonist; 1-10 muM) and ruthenium red (inhibitor of vanilloid response; 1-30 muM) concentration-dependently inhibited the nicotine-induced vasodilation without affecting the vasodilator response to exogenous CGRP. 4 Nicotine-induced vasodilation was not inhibited by treatment with 3,4-dihydroxyphenylalanine (DOPA) receptor antagonist (L-DOPA cyclohexyl ester; 0.001- 10 muM), dopamine D1 receptor-selective antagonist (SCH23390; 1-10 muM), dopamine D2 receptor antagonist (haloperidol; 0.1-0.5 muM), ATP P2x receptor-desensitizing agonist (alpha,beta-methylene ATP; 1-10 muM), adenosine A(2) receptor antagonist (8(p-sulfophenyl) theophylline; 10-50 muM) or neuropeptide Y (NPY)-Y1 receptor antagonist (BIBP3226; 0.1-0.5 muM). 5 Immunohistochemical staining of the mesenteric artery showed dense innervation of CGRP- and vanilloid receptor-1-positive nerves, with both immunostainings appearing in the same neuron. The mesenteric artery was also densely innervated by NPY-positive nerves. Double immunostainings showed that both NPY and CGRP immunoreactivities appeared in the same neuron of the artery. 6 These results suggest that nicotine acts on presynaptic nicotinic receptors to release adrenergic neurotransmitter(s) or related substance(s), which then stimulate vanilloid receptor-1 on CGRPergic nerves, resulting in CGRP release and vasodilation.
引用
收藏
页码:1137 / 1146
页数:10
相关论文
共 29 条
[1]
RUTHENIUM RED AS A CAPSAICIN ANTAGONIST [J].
AMANN, R ;
MAGGI, CA .
LIFE SCIENCES, 1991, 49 (12) :849-856
[2]
Localization of dopamine receptor subtypes in systemic arteries [J].
Amenta, F ;
Barili, P ;
Bronzetti, E ;
Felici, L ;
Mignini, F ;
Ricci, A .
CLINICAL AND EXPERIMENTAL HYPERTENSION, 2000, 22 (03) :277-288
[3]
ANWAR N, 1980, J PHARM PHARMACOL, V33, P150
[4]
NONADRENERGIC NEURAL VASODILATOR MECHANISMS [J].
BEVAN, JA ;
BRAYDEN, JE .
CIRCULATION RESEARCH, 1987, 60 (03) :309-326
[5]
NICOTINE-INDUCED SKELETAL-MUSCLE VASODILATION IS MEDIATED BY RELEASE OF EPINEPHRINE FROM NERVE-TERMINALS [J].
DIANA, JN ;
QIAN, SF ;
HEESCH, CM ;
BARRON, KW ;
CHIEN, CY .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 259 (06) :H1718-H1729
[6]
Capsazepine block of voltage-activated calcium channels in adult rat dorsal root ganglion neurones in culture [J].
Docherty, RJ ;
Yeats, JC ;
Piper, AS .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 121 (07) :1461-1467
[7]
NEUROGENIC VASODILATION AND RELEASE OF CALCITONIN GENE-RELATED PEPTIDE (CGRP) FROM PERIVASCULAR NERVES IN THE RAT MESENTERIC-ARTERY [J].
FUJIMORI, A ;
SAITO, A ;
KIMURA, S ;
WATANABE, T ;
UCHIYAMA, Y ;
KAWASAKI, H ;
GOTO, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 165 (03) :1391-1398
[8]
L-DOPA cyclohexyl ester is a novel potent and relatively stable competitive antagonist against L-DOPA among several L-DOPA ester compounds [J].
Furukawa, N ;
Goshima, Y ;
Miyamae, T ;
Sugiyama, Y ;
Shimizu, M ;
Ohshima, E ;
Suzuki, F ;
Arai, N ;
Fujita, K ;
Misu, Y .
JAPANESE JOURNAL OF PHARMACOLOGY, 2000, 82 (01) :40-47
[9]
HAASS M, 1991, N-S ARCH PHARMACOL, V344, P527
[10]
MULTIPLE MECHANISMS FOR THE EFFECTS OF CAPSAICIN, BRADYKININ AND NICOTINE ON CGRP RELEASE FROM TRACHEAL AFFERENT NERVES - ROLE OF PROSTAGLANDINS, SYMPATHETIC-NERVES AND MAST-CELLS [J].
HUA, XY ;
JINNO, S ;
BACK, SM ;
TAM, EK ;
YAKSH, TL .
NEUROPHARMACOLOGY, 1994, 33 (10) :1147-1154